BOC Sciences is dedicated to providing impactful solutions for the development of deuterated compounds for use in the pharmaceutical industry. Our consulting services not only involve the synthesis stage of a compound, but also across other stages of drug development, providing experienced insights and strategic oversight to ensure that you develop the best preclinical strategy for better, more positive outcomes.
Our consulting services are designed to help clients develop new treatments to meet broader medical needs, or to optimize existing treatments. We communicate scientific information in the language of successful regulatory submissions, balance risk and differentiate medicines from a competitive perspective, saving millions in R&D costs.
BOC Sciences' staff includes pharmaceutical and medical scientists and regulatory experts with years of experience supporting the discovery and development of new drugs, working to develop critical medicines for biopharmaceutical companies worldwide. From the initial stages of working with you, we provide data-driven and regulatory science-based data on drug safety, efficacy, risk/benefit and relative efficacy, ensuring excellence at every step of regulatory interaction and submission, while increasing your commercial reach the likelihood of success.
BOC Sciences has been deeply involved in the field of deuterium technology for many years, and is committed to developing innovative drugs using proprietary platforms. Our consulting and services can cover all your needs, including:
BOC Sciences has always regarded intellectual property as the most valuable asset of the company and its customers. We have signed non-disclosure agreements with customers and employees before the project starts, and provide synthetic route design and synthesis services in strict accordance with the terms of the non-disclosure agreement, striving to provide customers with target compounds in the shortest time possible.
BOC Sciences' DCL™ platform provides a deuterium strategy for both high-end custom markets and basic product needs. Our main business areas cover drug development, omics analysis, scientific research testing, and other markets, and strive to promote the development of biomedicine and scientific research.